Home > Business Model


R&D-based and product-driven pharmaceutical company

R&D at high efficiency

  • First in class and best in class products with worldwide IP protection
  • Targeting 3.5 years from discovery to US IND
  • US IND trials up to proof-of-concept
  • China IND trials for 'First Class New Drug' registration, fast market entry and price protection